Periviable birth: Executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Academy of Pediatrics, and American College of Obstetricians and Gynecologists

Obstetrics and Gynecology

Volumn 123, Issue 5, 2014, Pages 1083-1096

  Raju, Tonse N K ^a   Mercer, Brian M ^a   Burchfield, David J ^a   Joseph Jr , Gerald F ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; MAGNESIUM SULFATE; UTERUS SPASMOLYTIC AGENT;

BIRTH WEIGHT; BRAIN HEMORRHAGE; CESAREAN SECTION; ENVIRONMENTAL TEMPERATURE; EVIDENCE BASED PRACTICE; FAMILY COUNSELING; FAMILY DECISION MAKING; FOLLOW UP; GESTATIONAL AGE; HUMAN; HYPOTHERMIA; INTENSIVE CARE; LIVE BIRTH; MEDICAL SOCIETY; MORBIDITY; MORTALITY; NATIONAL HEALTH ORGANIZATION; NEWBORN CARE; NEWBORN DEATH; NEWBORN MORTALITY; OBSTETRIC PROCEDURE; PERINATAL CARE; PERIVIABLE BIRTH; PRACTICE GUIDELINE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PRIORITY JOURNAL; RESUSCITATION; REVIEW; RISK FACTOR; STILLBIRTH; WORKSHOP; COUNSELING; DOCTOR PATIENT RELATION; FEMALE; INFANT; INFANT MORTALITY; NEWBORN; OBSTETRIC LABOR, PREMATURE; PATIENT CARE PLANNING; PATIENT EDUCATION; PREGNANCY; PREMATURE BIRTH; PSYCHOLOGY;

CESAREAN SECTION; COUNSELING; FEMALE; HUMANS; INFANT; INFANT MORTALITY; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; OBSTETRIC LABOR, PREMATURE; PATIENT CARE PLANNING; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; PREGNANCY; PREMATURE BIRTH;

EID: 84900389383     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000243     Document Type: Review

References (60)

1. Campbell DE, Fleischman AR. Limits of viability: dilemmas, decisions, and decision makers. Am J Perinatol 2001;18: 117-28.
2. Perinatal care at the threshold of viability. ACOG Practice Bulletin No. 38. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;100: 617-24.
3. MacDonald H; American Academy of Pediatrics. Committee on Fetus and Newborn. Perinatal care at the threshold of viability. Pediatrics 2002;110: 1024-7.
4. Batton DG; Committee on Fetus and Newborn. Clinical report - antenatal counseling regarding resuscitation at an extremely low gestational age. Pediatrics 2009;124: 422-7.
5. Pignotti MS. The definition of human viability: a historical perspective. Acta Paediatr 2010;99: 33-6.
6. Khan RA, Burgoyne L, O'Connell MP, Dempsey EM. Resuscitation at the limits of viability - an Irish perspective. Acta Paediatr 2009;98: 1456-60.
7. Kollée LA, Cuttini M, Delmas D, Papiernik E, den Ouden AL, Agostino R, et al; MOSAIC Research group. Obstetric interventions for babies born before 28 weeks of gestation in Europe: results of the MOSAIC study. BJOG 2009;116: 1481-91.
8. Zecca E, de Luca D, Costa S, Marras M, de Turris P, Romagnoli C. Delivery room strategies and outcomes in preterm infants with gestational age 24-28 weeks. J Matern Fetal Neonatal Med 2006;19: 569-74.
9. Louis JM, Ehrenberg HM, Collin MF, Mercer BM. Perinatal intervention and neonatal outcomes near the limit of viability. Am J Obstet Gynecol 2004;191: 1398-402.
10. Verlato G, Gobber D, Drago D, Chiandetti L, Drigo P; Working Group of Intensive Care in the Delivery Room of Extremely Premature Newborns. Guidelines for resuscitation in the delivery room of extremely preterm infants. J Child Neurol 2004;19: 31-4.
11. Sanders MR, Donohue PK, Oberdorf MA, Rosenkrantz TS, Allen MC. Perceptions of the limit of viability: neonatologists' attitudes toward extremely preterm infants. J Perinatol 1995;15: 494-502.
12. Allen MC, Donohue PK, Dusman AE. The limit of viability - neonatal outcome of infants born at 22 to 25 weeks' gestation. N Engl J Med 1993;329: 1597-601.
13. Andrews B, Lagatta J, Chu A, Plesha-Troyke S, Schreiber M, Lantos J, et al. The nonimpact of gestational age on neurodevelopmental outcome for ventilated survivors born at 23-28 weeks of gestation. Acta Paediatr 2012;101: 574-8.
14. Lau C, Ambalavanan N, Chakraborty H, Wingate MS, Carlo WA. Extremely low birth weight and infant mortality rates in the United States. Pediatrics 2013;151: 855-60.
15. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010;126: 443-56.
16. De Jesus LC, Pappas A, Shankaran S, Kendrick D, Das A, Higgins RD, et al. Risk factors for post-neonatal intensive care unit discharge mortality among extremely low birth weight infants. J Pediatr 2012;161: 70-4.e1-2.
17. Salihu HM, Emusu D, Aliyu ZY, Kirby RS, Alexander GR. Survival of "pre-viable" infants in the United States. Wien Klin Wochenschr 2005;117: 324-32.
18. Hoekstra RE, Ferrara TB, Couser RJ, Payne NR, Connett JE. Survival and long-term neurodevelopmental outcome of extremely premature infants born at 23-26 weeks' gestational age at a tertiary center. Pediatrics 2004;113:e1-6.
19. Kamath BD, Box TL, Simpson M, Hernández JA. Infants born at the threshold of viability in relation to neonatal mortality: Colorado, 1991 to 2003. J Perinatol 2008;28: 354-60.
20. Iams JD, Mercer BM; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. What we have learned about antenatal prediction of neonatal morbidity and mortality. Semin Perinatol 2003;27: 247-52.
21. Donohue PK, Boss RD, Shepard J, Graham E, Allen MC. Intervention at the border of viability: perspective over a decade. Arch Pediatr Adolesc Med 2009;163: 902-6.
22. Morse SB, Wu SS, Ma C, ArietM, ResnickM, Roth J. Racial and gender differences in the viability of extremely low birth weight infants: a population-based study. Pediatrics 2006;117:e106-12.
23. Mohamed MA, Nada A, Aly H. Day-by-day postnatal survival in very low birth weight infants. Pediatrics 2010;126:e360-6.
24. Petrova A,Mehta R, AnwarM, HiattM, Hegyi T. Impact of race and ethnicity on the outcome of preterm infants below 32 weeks gestation. J Perinatol 2003;23: 404-8.
25. Tyson JE, Parikh NA, Langer J, Green C, Higgins RD; National Institute of Child Health and Human Development Neonatal Research Network. Intensive care for extreme prematurity - moving beyond gestational age. N Engl J Med 2008;358: 1672-81.
26. Batton B, Burnett C, Verhulst S, Batton D. Extremely preterm infant mortality rates and cesarean deliveries in the United States. Obstet Gynecol 2011;118: 43-8.
27. Mehler K, Grimme J, Abele J, Huenseler C, Roth B, Kribs A. Outcome of extremely low gestational age newborns after introduction of a revised protocol to assist preterm infants in their transition to extrauterine life. Acta Paediatr 2012;101: 1232-9.
28. Kyser KL, Morriss FH Jr, Bell EF, Klein JM, Dagle JM. Improving survival of extremely preterm infants born between 22 and 25 weeks of gestation. Obstet Gynecol 2012;119: 795-800.
29. Lee HC, Green C, Hintz SR, Tyson JE, Parikh NA, Langer J, et al. Prediction of death for extremely premature infants in a population-based cohort. Pediatrics 2010;126:e644-50.
30. Smith PB, Ambalavanan N, Li L, Cotten CM, Laughon M, Walsh MC, et al. Approach to infants born at 22 to 24 weeks' gestation: relationship to outcomes of more-mature infants. Pediatrics 2012;129:e1508-16.
31. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR. Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med 2000;343: 378-84.
32. Marlow N, Wolke D, Bracewell MA, Samara M; EPICure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 2005; 352: 9-19.
33. Moore GP, Lemyre B, Barrowman N, Daboval T. Neurodevelopmental outcomes at 4 to 8 years of children born at 22 to 25 weeks' gestational age. a meta-analysis. JAMA Pediatr 2013; 167: 967-74.
34. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. The Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No: CD 004661. doi: 10. 1002/14651858.CD004661.pub3.
35. Althuisius SM, Dekker GA, Hummel P, van Geijn HP; Cervical Incompetence Prevention Randomized Cerclage Trial. Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 2003;189: 907-10.
36. Daskalakis G, Papantoniou N, Mesogitis S, Antsaklis A. Management of cervical insufficiency and bulging fetal membranes. Obstet Gynecol 2006;107: 221-6.
37. Debby A, Sadan O, Glezerman M, Golan A. Favorable outcome following emergency second trimester cerclage. Int J Gynaecol Obstet 2007;96: 16-9.
38. Stupin JH, David M, Siedentopf JP, Dudenhausen JW. Emergency cerclage versus bed rest for amniotic sac prolapse before 27 gestational weeks. A retrospective, comparative study of 161 women. Eur J Obstet Gynecol Reprod Biol 2008;139: 32-7.
39. Gonzales LW, Ballard PL, Ertsey R, Williams MC. Glucocorticoids and thyroid hormones stimulate biochemical and morphological differentiation of human fetal lung in organ culture. J Clin Endocrinol Metab 1986;62: 678-91.
40. Carlo WA, McDonald SA, Fanaroff AA, Vohr BR, Stoll BJ, Ehrenkranz RA, et al. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation. JAMA 2011;306: 2348-58.
41. Mori R, Kusuda S, Fujimura M; Neonatal Research Network Japan. Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 weeks of gestation. J Pediatr 2011;159: 110-14.e1.
42. Chawla S, Natarajan G, Rane S, Thomas R, Cortez J, Lua J. Outcomes of extremely low birth weight infants with varying doses and intervals of antenatal steroid exposure. J Perinat Med 2010;38: 419-23.
43. Chawla S, Bapat R, Pappas A, Bara R, Zidan M, Natarajan G. Neurodevelopmental outcome of extremely premature infants exposed to incomplete, no or complete antenatal steroids. J Matern Fetal Neonatal Med 2013;26: 1542-7.
44. Costantine MM, Weiner SJ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstet Gynecol 2009;114: 354-64.
45. Alfirevic Z, Milan SJ, Livio S. Caesarean section versus vaginal delivery for preterm birth in singletons. The Cochrane Database of Systematic Reviews 2013, Issue 9. Art. CD 000078. doi: 10.1002/14651858.cd000078.pub3.
46. Lee HC, Gould JB. Survival rates and mode of delivery for vertex preterm neonates according to small- or appropriatefor- gestational-age status. Pediatrics 2006;118:e1836-44.
47. Costeloe KL, Hennessy EM, Haider S, Stacey F, Marlow N, Draper ES. Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies). BMJ 2012;345:e7976.
48. Wylie BJ, Davidson LL, Batra M, Reed SD. Method of delivery and neonatal outcome in very low-birthweight vertex-presenting fetuses. Am J Obstet Gynecol 2008;198: 640.e1-7.
49. Reddy UM, Zhang J, Sun L, Chen Z, Raju TN, Laughon SK. Neonatal mortality by attempted route of delivery in early preterm birth. Am J Obstet Gynecol 2012;207: 117. e1-8.
50. Chervenak FA, McCullough LB, Levene MI. An ethically justified, clinically comprehensive approach to peri-viability: gynaecological, obstetric, perinatal and neonatal dimensions. J Obstet Gynaecol 2007;27: 3-7.
51. Perlman JM, Wyllie J, Kattwinkel J, Atkins DL, Chameides L, Goldsmith JP, et al. Part 11: neonatal resuscitation: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation 2010;122:S516-38.
52. Wyckoff MH, Salhab WA, Heyne RJ, Kendrick DE, Stoll BJ, Laptook AR; National Institute of Child Health and Human Development Neonatal Research Network. Outcome of extremely low birth weight infants who received delivery room cardiopulmonary resuscitation. J Pediatr 2012;160: 239-44.e2.
53. Laptook AR, Salhab W, Bhaskar B; Neonatal Research Network. Admission temperature of low birth weight infants: predictors and associated morbidities. Pediatrics 2007;119: e643-9.
54. World Health Organization, Maternal and Newborn Health/Safe Motherhood. Thermal protection of the newborn: a practical guide. Geneva (Switzerland): World Health Organization; 1997.
55. Been JV, Degraeuwe PL, Kramer BW, Zimmermann LJ. Antenatal steroids and neonatal outcome after chorioamnionitis: a meta-analysis. BJOG 2011;118: 113-22.
56. Eriksson L, Haglund B, Ewald U, Odlind V, Kieler H. Short and long-term effects of antenatal corticosteroids assessed in a cohort of 7,827 children born preterm. Acta Obstet Gynecol Scand 2009;88: 933-8.
57. Abbasi S, Oxford C, Gerdes J, Sehdev H, Ludmir J. Antenatal corticosteroids prior to 24 weeks' gestation and neonatal outcome of extremely low birth weight infants. Am J Perinatol 2010;27: 61-6.
58. Fowlie PW, Davis PG,McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterminfants. The Cochrane Database of Systematic Reviews 2010, Issue 7. Art No.: CD 000174. doi: 10.1002/14651858. CD000174.pub2.
59. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001;344: 1966-72.
60. Janvier A, Lorenz JM, Lantos JD. Antenatal counselling for parents facing an extremely preterm birth: limitations of the medical evidence. Acta Paediatr 2012;101: 800-4.